<b>Conclusions</b>  Collectively, these findings offer valuable genomic insights that could inform the personalized clinical care of patients with NSCLC harboring <i>ALK</i> fusions within the context of precision medicine. Here, ALK is linked to non-small cell lung carcinoma.